Krishna Institute of Medical Sciences Limited has successfully completed its postal ballot process, with shareholders providing overwhelming support for the company's fundraising initiative through qualified institutions placement (QIP). The healthcare provider disclosed the voting results to stock exchanges on April 17, 2026, following the conclusion of the remote e-voting process.

Voting Process and Timeline

The postal ballot process was conducted entirely through remote e-voting, with the voting window open from March 17, 2026 at 9:00 AM IST to April 15, 2026 at 5:00 PM IST. The company engaged MUFG Intime India Private Limited (formerly Link Intime India Private Limited) to facilitate the e-voting process for shareholders.

Resolution Details and Voting Results

The special resolution pertained to the issuance of equity shares to investors by way of qualified institutions placement for raising funds. The voting results demonstrated strong shareholder confidence in the company's fundraising strategy.

Category-wise Voting Pattern

The voting results showed unanimous support across all shareholder categories. Promoter and promoter group shareholders, holding 136,489,330 shares, cast 110,694,350 votes representing 81.10% of their holdings, with 100% votes in favour. Public institutions demonstrated strong participation with 164,796,564 votes cast from their holding of 188,577,416 shares, achieving 87.39% voting participation with complete support for the resolution.

Scrutinizer's Validation

Krishna Rao Inturi, proprietor of IKR & Associates and practicing company secretary, served as the scrutinizer for the postal ballot process. His report dated April 16, 2026, confirmed that the special resolution was passed with requisite majority. The scrutinizer noted that 469 members voted in favour of the resolution while only 4 members voted against, with no invalid votes recorded during the process.

Regulatory Compliance and Next Steps

The company has fulfilled its disclosure obligations under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting results have been communicated to both BSE and NSE, and the information has been uploaded on the company's website and the e-voting platform. With the resolution deemed passed on April 15, 2026, the company can now proceed with its qualified institutions placement plans to raise funds for its business operations.

Krishna Institute of Medical Sciences Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange and National Stock Exchange of India for the quarter ended 31st March, 2026. The submission was made on 13th April, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The healthcare company submitted the mandatory Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 to both stock exchanges. The certificate covers the company's compliance activities for the fourth quarter of fiscal year 2026.

Registrar Confirmation

The certificate was issued by MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, which serves as the company's registrar and share transfer agent. The registrar confirmed compliance with dematerialisation processes and adherence to prescribed timelines during the quarter.

MUFG Intime India confirmed that securities received from depository participants for dematerialisation during the quarter ended 31st March, 2026 were properly processed. The registrar verified that all security certificates received for dematerialisation were confirmed or rejected within prescribed timelines, and that depositories' names were appropriately substituted in the register of members.

Corporate Filing Process

The submission was signed by Nagajayanthi J. R, Company Secretary and Compliance Officer of Krishna Institute of Medical Sciences Limited. The filing ensures the company maintains its regulatory compliance status with stock exchange requirements.

The quarterly compliance certificate represents part of the company's ongoing regulatory obligations to maintain transparency and proper governance standards as a publicly listed healthcare institution.